Our supporters

TIF works with a network of pharmaceutical industries and research foundations that share a common interest in haemoglobin disorders (thalassaemia and sickle cell disease) and in the development of technologies relating to their prevention, treatment and monitoring.

TIF would like to thank the following partners:

See TIF’s Transparency statement

TIF Transparency Statement